ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,460.48
      -0.41%
      US Tech 100
      19,181.60
      -0.43%
      Dow Jones
      39,118.86
      -0.12%
      Brent Oil
      84.85
      0.00%
      Bitcoin
      61,829.13
      1.54%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Mesoblast Limited (MESO)

      7. Mesoblast Limited (MESO) News

      MESO

      Mesoblast (MESO)

      Mesoblast Limited
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:MESO
      DateTimeSourceHeadlineSymbolCompany
      07/14/20224:01PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MESOMesoblast Limited
      07/11/20228:40PMGlobeNewswire Inc.Rexlemestrocel-L to be Highlighted at Maxim’s Panel on Late-Stage Advancements in Heart Failure Therapeutics and ManagementNASDAQ:MESOMesoblast Limited
      06/22/20226:46AMTipRanksMaxim Group Thinks Mesoblast’s Stock is Going to RecoverNASDAQ:MESOMesoblast Limited
      06/17/20226:04AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MESOMesoblast Limited
      06/09/20227:00AMGlobeNewswire Inc.Mesoblast Key Opinion Leader Event Series for Investors & AnalystsNASDAQ:MESOMesoblast Limited
      06/08/20225:05AMTipRanksDawson James Thinks Mesoblast’s Stock is Going to RecoverNASDAQ:MESOMesoblast Limited
      06/03/20229:27AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MESOMesoblast Limited
      06/03/20228:15AMTipRanksAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Mesoblast (MESO) and Immatics (IMTX)NASDAQ:MESOMesoblast Limited
      06/03/20226:05AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MESOMesoblast Limited
      05/31/20228:15PMGlobeNewswire Inc.Operational Highlights and Financial Results for the Period Ended March 31, 2022NASDAQ:MESOMesoblast Limited
      05/23/20226:04AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MESOMesoblast Limited
      04/28/20228:35PMGlobeNewswire Inc.Appendix 4C Quarterly Activity ReportNASDAQ:MESOMesoblast Limited
      04/20/20226:07AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MESOMesoblast Limited
      04/11/20226:07AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MESOMesoblast Limited
      03/30/20227:53AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MESOMesoblast Limited
      03/23/20228:40PMGlobeNewswire Inc.Philip R. Krause, M.D., Former FDA Deputy Chief for Vaccines, Joins Mesoblast BoardNASDAQ:MESOMesoblast Limited
      03/03/20227:36AMTipRanksAnalysts Conflicted on These Healthcare Names: Mesoblast (MESO), Intercept Pharma (ICPT) and Chimerix (CMRX)NASDAQ:MESOMesoblast Limited
      02/28/20226:08AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MESOMesoblast Limited
      02/25/20227:40AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MESOMesoblast Limited
      02/24/20225:30PMGlobeNewswire Inc.Operational Highlights and Financial Results for the Period Ended December 31, 2021NASDAQ:MESOMesoblast Limited
      02/24/20225:57AMGlobeNewswire Inc.Mesoblast Corporate Update and Financial Results WebcastNASDAQ:MESOMesoblast Limited
      02/22/20227:38AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MESOMesoblast Limited
      02/20/20226:19PMGlobeNewswire Inc.Rapid Improvement and Remission in Patients With Refractory Ulcerative Colitis and Crohn’s Colitis After Direct Injection of Remestemcel-L by ColonoscopyNASDAQ:MESOMesoblast Limited
      02/01/20227:20PMGlobeNewswire Inc.Mesoblast Appoints Dr. Eric Rose as Chief Medical OfficerNASDAQ:MESOMesoblast Limited
      02/01/20226:28AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MESOMesoblast Limited
      01/30/20227:16PMGlobeNewswire Inc.Appendix 4C Quarterly Activity ReportNASDAQ:MESOMesoblast Limited
      01/24/20226:45PMGlobeNewswire Inc.Mesoblast to Participate in Edison Group’s Global Healthcare “Open House” Virtual Conference From January 25-27th, 2022NASDAQ:MESOMesoblast Limited
      01/19/20228:29AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MESOMesoblast Limited
      01/19/20226:07AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MESOMesoblast Limited
      01/11/20228:26PMGlobeNewswire Inc.Single Dose of Mesoblast’s Allogeneic Cell Therapy Provides Durable Pain Reduction for at Least Three Years in Patients With Degenerative Disc DiseaseNASDAQ:MESOMesoblast Limited
       Showing the most relevant articles for your search:NASDAQ:MESO